To investigate the signaling pathways pivotal for IL-11–driven pulmonary fibrosis, we assessed the activation status of SMAD2, ERK, and STAT3 by Western blotting of lung homogenates from the PBS-treated group, siIL11@PPGC NP–treated group, or healthy controls. The gene discussed is SMAD2; the disease is pulmonary fibrosis.